Replies to post #219154 on Biotech Values

[randychub]

NBRV. That was also addressed as mild to moderate around the same area in the conf call. Do you disagree with their comments or did you. It have a chance to listen. Thank you! Randy

[DewDiligence]

NBRV sells 20.91M* shares @$2.75—a 22% discount to Wednesday’s close:

https://finance.yahoo.com/news/nabriva-therapeutics-announces-pricing-public-000000871.html

*Assuming exercise of underwriter’s option.